Search

Objective To explore the clinical efficacy and safety of Changlong Kaixuan Xingqiao powder in treating tinnitus of spleen deficiency and blood stasis. Methods A total of 90 patients with tinnitus of spleen deficiency and blood stasis who visited the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University from February 1 to December 31, 2022 were selected and randomly divided into the treatment group(45 cases) and the control group (45 cases) by the random number table method. The scores of tinnitus evaluation questionnaire (TEQ), tinnitus handicap inventory (THI), visual analogue scale (VAS).as well as Traditional Chinese Medicine (TCM) syndrome integral, clinical total effective rate, and incidence of adverse reactions were compared between the two groups. Results There were no statistically significant differences in the TEQ, THI, VAS scores, and TCM syndrome integral between the two groups before treatment (P>0.05). After treatment, the TEQ, THI, VAS scores, and TCM syndrome integral of the two groups were lower than those before treatment. with statistically significant differences (P<0.05). After treatment, the TEQ, THI, VAS scores, and TCM syndrome integral of the treatment group were lower than those of the control group, with statistically significant differences (P<0.05). The clinical total effective rate of the treatment group was higher than that of the control group, with statistically significant differences (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion The clinical efficacy of Changlong Kaixuan Xingqiao powder in treating tinnitus is accurate and safe. [ABSTRACT FROM AUTHOR]